Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rieckmann

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Multiple Sclerosis and Related Disorders|December 15, 2017
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group, Peter Rieckmann, Diego Centonze, et al.
Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis diseaseHervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
G3 (Bethesda, Md.)|May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis PatientsA Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Brain : a Journal of Neurology|June 7, 2013
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis, Christina M Lill, Brit-Maren M Schjeide, et al.
Journal of Medical Genetics|October 18, 2015
Genome-wide significant association with seven novel multiple sclerosis risk lociChristina M Lill, Felix Luessi, Antonio Alcina, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Multiple Sclerosis and Related Disorders|December 15, 2017
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group, Peter Rieckmann, Diego Centonze, et al.
Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis diseaseHervé Perron, Raphaëlle Germi, Corinne Bernard, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
G3 (Bethesda, Md.)|May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis PatientsA Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Brain : a Journal of Neurology|June 7, 2013
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis, Christina M Lill, Brit-Maren M Schjeide, et al.
Journal of Medical Genetics|October 18, 2015
Genome-wide significant association with seven novel multiple sclerosis risk lociChristina M Lill, Felix Luessi, Antonio Alcina, et al.
Pageof 13